No retraction, correction or concern found when last checked on Oct 16, 2026.

Butyrate producers, “The Sentinel of Gut”: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics

Vineet Singh, GyuDae Lee, HyunWoo Son and 4 more (opens in a new tab)

Frontiers in Microbiology · 2023 · Review · CC BY

doi:10.3389/fmicb.2022.1103836 (opens in a new tab)

Abstract

Gut-microbial butyrate is a short-chain fatty acid (SCFA) of significant physiological importance than the other major SCFAs (acetate and propionate). Most butyrate producers belong to the Clostridium cluster of the phylum Firmicutes, such as Faecalibacterium , Roseburia , Eubacterium , Anaerostipes , Coprococcus , Subdoligranulum , and Anaerobutyricum . They metabolize carbohydrates via the butyryl-CoA: acetate CoA-transferase pathway and butyrate kinase terminal enzymes to produce most of butyrate. Although, in minor fractions, amino acids can also be utilized to generate butyrate via glutamate and lysine pathways. Butyrogenic microbes play a vital role in various gut-associated metabolisms. Butyrate is used by colonocytes to generate energy, stabilizes hypoxia-inducible factor to maintain the anaerobic environment in the gut, maintains gut barrier integrity by regulating Claudin-1 and synaptopodin expression, limits pro-inflammatory cytokines (IL-6, IL-12), and inhibits oncogenic pathways (Akt/ERK, Wnt, and TGF-β signaling). Colonic butyrate producers shape the gut microbial community by secreting various anti-microbial substances, such as cathelicidins, reuterin, and β-defensin-1, and maintain gut homeostasis by releasing anti-inflammatory molecules, such as IgA, vitamin B, and microbial anti-inflammatory molecules. Additionally, butyrate producers, such as Roseburia , produce anti-carcinogenic metabolites, such as shikimic acid and a precursor of conjugated linoleic acid. In this review, we summarized the significance of butyrate, critically examined the role and relevance of butyrate producers, and contextualized their importance as microbial therapeutics.

References 173

1.
The Ability of AhR Ligands to Attenuate Delayed Type Hypersensitivity Reaction Is Associated With Alterations in the Gut Microbiota · 2021
Not checked
2.
Abrahamsson T. Jakobsson H. Andersson A. F. Björkstén B. Engstrand L. Jenmalm M. (2014 ). Low gut microbiota diversity in early infancy precedes asthma at school age. Clin. Exp. Allergy 44, 842–850. doi:, PMID:
Not in our library10.1111/cea.12253 (opens in a new tab)
3.
Ahlawat S. Asha S. K. K. (2021 ). Gut–organ axis: a microbial outreach and networking. Lett. Appl. Microbiol. 72, 636–668. doi:, PMID:
Not in our library10.1111/lam.13333 (opens in a new tab)
4.
Akitsu A. Iwakura Y. (2018 ). Interleukin-17-producing γδ T (γδ17) cells in inflammatory diseases. Immunology 155, 418–426. doi:, PMID:
Not in our library10.1111/imm.12993 (opens in a new tab)
5.
Alessi A. M. Gray V. Farquharson F. M. Flores-López A. Shaw S. Stead D.. (2020 ). β-Glucan is a major growth substrate for human gut bacteria related to Coprococcus eutactus. Environ. Microbiol. 22, 2150–2164. doi:, PMID:
Not in our library10.1111/1462-2920.14977 (opens in a new tab)
6.
Allen-Vercoe E. Daigneault M. White A. Panaccione R. Duncan S. H. Flint H. J.. (2012 ). Anaerostipes hadrus comb. nov., a dominant species within the human colonic microbiota; reclassification of Eubacterium hadrum Moore et al. Anaerobe 18, 523–529. doi:, PMID:
Not in our library10.1016/j.anaerobe.2012.09.002 (opens in a new tab)
7.
Altemani F. Barrett H. L. Gomez-Arango L. Josh P. David McIntyre H. Callaway L. K.. (2021 ). Pregnant women who develop preeclampsia have lower abundance of the butyrate-producer Coprococcus in their gut microbiota. Pregnancy Hypertens. 23, 211–219. doi:, PMID:
Not in our library10.1016/j.preghy.2021.01.002 (opens in a new tab)
8.
Alves-Santos A. M. Sugizaki C. S. A. Lima G. C. Naves M. M. V. (2020 ). Prebiotic effect of dietary polyphenols: a systematic review. J. Funct. Foods 74:104169
Not in our library10.1016/j.jff.2020.104169 (opens in a new tab)
9.
Anderson C. J. Kendall M. M. (2017 ). Salmonella enterica serovar Typhimurium strategies for host adaptation. Front. Microbiol. 8:1983. doi:, PMID:
Not in our library10.3389/fmicb.2017.01983 (opens in a new tab)
10.
Antharam V. C. Li E. C. Ishmael A. Sharma A. Mai V. Rand K. H.. (2013 ). Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J. Clin. Microbiol. 51, 2884–2892. doi:, PMID:
Not in our library10.1128/jcm.00845-13 (opens in a new tab)
11.
Appert O. Garcia A. R. Frei R. Roduit C. Constancias F. Neuzil-Bunesova V.. (2020 ). Initial butyrate producers during infant gut microbiota development are endospore formers. Environ. Microbiol. 22, 3909–3921. doi:, PMID:
Not in our library10.1111/1462-2920.15167 (opens in a new tab)
12.
Bang S.-J. Kim G. Lim M. Y. Song E.-J. Jung D.-H. Kum J.-S.. (2018 ). The influence of in vitro pectin fermentation on the human fecal microbiome. AMB Express 8:98
Not in our library10.1186/s13568-018-0629-9 (opens in a new tab)
13.
Microbial Metabolic Networks at the Mucus Layer Lead to Diet-Independent Butyrate and Vitamin B 12 Production by Intestinal Symbionts · 2017
No notice
14.
Bisgaard H. Li N. Bonnelykke K. Chawes B. L. K. Skov T. Paludan-Müller G.. (2011 ). Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J. Allergy Clin. Immunol. 128:e5, 646–652.e5
Not in our library10.1016/j.jaci.2011.04.060 (opens in a new tab)
15.
Butyrate Producers as Potential Next-Generation Probiotics: Safety Assessment of the Administration of Butyricicoccus pullicaecorum to Healthy Volunteers · 2018
No notice
16.
Bothe M. K. Maathuis A. J. H. Bellmann S. Van der Vossen J. M. B. M. Berressem D. Koehler A.. (2017 ). Dose-dependent prebiotic effect of lactulose in a computer-controlled in vitro model of the human large intestine. Nutrients 9:767. doi:, PMID:
Not in our library10.3390/nu9070767 (opens in a new tab)
17.
Braune A. Gütschow M. Engst W. Blaut M. (2001 ). Degradation of quercetin and luteolin by Eubacterium ramulus. Appl. Environ. Microbiol. 67, 5558–5567. doi:, PMID:
Not in our library10.1128/aem.67.12.5558-5567.2001 (opens in a new tab)
18.
Production of butyrate from lysine and the Amadori product fructoselysine by a human gut commensal · 2015
No notice
19.
Mutual Metabolic Interactions in Co-cultures of the Intestinal Anaerostipes rhamnosivorans With an Acetogen, Methanogen, or Pectin-Degrader Affecting Butyrate Production · 2019
Not checked
20.
Bultman S. J. (2016 ). The microbiome and its potential as a cancer preventive intervention. Seminars Oncol. 43, 97–106. doi:, PMID:
Not in our library10.1053/j.seminoncol.2015.09.001 (opens in a new tab)
21.
Bultman S. J. Jobin C. (2014 ). Microbial-derived butyrate: an oncometabolite or tumor-suppressive metabolite? Cell Host Microbe 16, 143–145. doi:, PMID:
Not in our library10.1016/j.chom.2014.07.011 (opens in a new tab)
22.
Camilleri M. Oduyebo I. Halawi H. (2016 ). Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions. American journal of physiology-gastrointestinal and liver. Physiology 311, G777–G784
Not in our library10.1152/ajpgi.00242.2016 (opens in a new tab)
23.
Canani R. B. Di Costanzo M. Leone L. Pedata M. Meli R. Calignano A. (2011 ). Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J. Gastroenterol. 17, 1519–1528. doi:, PMID:
Not in our library10.3748/wjg.v17.i12.1519 (opens in a new tab)
24.
Catalkaya G. Venema K. Lucini L. Rocchetti G. Delmas D. Daglia M.. (2020 ). Interaction of dietary polyphenols and gut microbiota: microbial metabolism of polyphenols, influence on the gut microbiota, and implications on host health. Food Front. 1, 109–133
Not in our library10.1002/fft2.25 (opens in a new tab)
25.
Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health · 2018
No notice
26.
Chang P. V. Hao L. Offermanns S. Medzhitov R. (2014 ). The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. 111, 2247–2252. doi:, PMID:
Not in our library10.1073/pnas.1322269111 (opens in a new tab)
27.
Chassard C. Delmas E. Robert C. Lawson P. A. Bernalier-Donadille A. (2012 ). Ruminococcus champanellensis sp. nov., a cellulose-degrading bacterium from human gut microbiota. Int. J. Syst. Evol. Microbiol. 62, 138–143
Not in our library10.1099/ijs.0.027375-0 (opens in a new tab)
28.
Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease · 2019
No notice
29.
Chen D. Jin D. Huang S. Wu J. Xu M. Liu T.. (2020 ). Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett. 469, 456–467. doi:, PMID:
Not in our library10.1016/j.canlet.2019.11.019 (opens in a new tab)
30.
Chen G. Ran X. Li B. Li Y. He D. Huang B.. (2018 ). Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine 30, 317–325. doi:, PMID:
Not in our library10.1016/j.ebiom.2018.03.030 (opens in a new tab)
31.
Chen W. Zhang S. Wu J. Ye T. Wang S. Wang P.. (2020 ). Butyrate-producing bacteria and the gut-heart axis in atherosclerosis. Clin. Chim. Acta 507, 236–241. doi:, PMID:
Not in our library10.1016/j.cca.2020.04.037 (opens in a new tab)
32.
The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy · 2019
Corrected
33.
Modulation of the human gut microbiota by dietary fibres occurs at the species level · 2016
No notice
34.
Compare D. Coccoli P. Rocco A. Nardone O. M. De Maria S. Cartenì M.. (2012 ). Gut–liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutr. Metab. Cardiovasc. Dis. 22, 471–476
Not in our library10.1016/j.numecd.2012.02.007 (opens in a new tab)
35.
Cresci G. A. Glueck B. McMullen M. R. Xin W. Allende D. Nagy L. E. (2017 ). Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury. J. Gastroenterol. Hepatol. 32, 1587–1597. doi:, PMID:
Not in our library10.1111/jgh.13731 (opens in a new tab)
36.
Cuff M. A. Lambert D. W. Shirazi-Beechey S. P. (2002 ). Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1. J. Physiol. 539, 361–371. doi:, PMID:
Not in our library10.1113/jphysiol.2001.014241 (opens in a new tab)
37.
Dalile B. Van Oudenhove L. Vervliet B. Verbeke K. (2019 ). The role of short-chain fatty acids in microbiota–gut–brain communication. Nat. Rev. Gastroenterol. Hepatol. 16, 461–478. doi:, PMID:
Not in our library10.1038/s41575-019-0157-3 (opens in a new tab)
38.
Damen B. Verspreet J. Pollet A. Broekaert W. F. Delcour J. A. CMJMN C.. (2011 ). Prebiotic effects and intestinal fermentation of cereal arabinoxylans and arabinoxylan oligosaccharides in rats depend strongly on their structural properties and joint presence. Mol. Nutr. Food Res. 55, 1862–1874
Not in our library10.1002/mnfr.201100377 (opens in a new tab)
39.
Dang A. T. Marsland B. J. (2019 ). Microbes, metabolites, and the gut–lung axis. Mucosal Immunol. 12, 843–850. doi:, PMID:
Not in our library10.1038/s41385-019-0160-6 (opens in a new tab)
40.
Das V. Kalita J. Pal M. (2017 ). Predictive and prognostic biomarkers in colorectal cancer: a systematic review of recent advances and challenges. Biomed. Pharmacother. 87, 8–19. doi:, PMID:
Not in our library10.1016/j.biopha.2016.12.064 (opens in a new tab)
41.
Del Bo C. Bernardi S. Cherubini A. Porrini M. Gargari G. Hidalgo-Liberona N.. (2021 ). A polyphenol-rich dietary pattern improves intestinal permeability, evaluated as serum zonulin levels, in older subjects: the MaPLE randomised controlled trial. Clin. Nutr. 40, 3006–3018. doi:, PMID:
Not in our library10.1016/j.clnu.2020.12.014 (opens in a new tab)
42.
Conjugated Linoleic Acid Effects on Cancer, Obesity, and Atherosclerosis: A Review of Pre-Clinical and Human Trials with Current Perspectives · 2019
No notice
43.
Devillard E. McIntosh F. M. Duncan S. H. Wallace R. J. (2007 ). Metabolism of linoleic acid by human gut bacteria: different routes for biosynthesis of conjugated linoleic acid. J. Bacteriol. 189, 2566–2570. doi:, PMID:
Not in our library10.1128/jb.01359-06 (opens in a new tab)
44.
The aryl hydrocarbon receptor as a mediator of host-microbiota interplay · 2020
No notice
45.
Duncan S. H. Aminov R. I. Scott K. P. Louis P. Stanton T. B. Flint H. J. (2006 ). Proposal of Roseburia faecis sp. nov., Roseburia hominis sp. nov. and Roseburia inulinivorans sp. nov., based on isolates from human faeces. Int. J. Syst. Evol. Microbiol. 56, 2437–2441. doi:, PMID:
Not in our library10.1099/ijs.0.64098-0 (opens in a new tab)
46.
Duncan S. H. Louis P. Flint H. J. (2004 ). Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microbiol. 70, 5810–5817. doi:, PMID:
Not in our library10.1128/aem.70.10.5810-5817.2004 (opens in a new tab)
47.
Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver Axis · 2013
No notice
48.
Endo A. Tanno H. Kadowaki R. Fujii T. Tochio T. (2022 ). Extracellular fructooligosaccharide degradation in Anaerostipes hadrus for co-metabolism with non-fructooligosaccharide utilizers. Biochem. Biophys. Res. Commun. 613, 81–86. doi:, PMID:
Not in our library10.1016/j.bbrc.2022.04.134 (opens in a new tab)
49.
The Common Gut Microbe Eubacterium hallii also Contributes to Intestinal Propionate Formation · 2016
No notice
50.
Engels C. Schwab C. Zhang J. Stevens M. J. A. Bieri C. Ebert M.-O.. (2016b ). Acrolein contributes strongly to antimicrobial and heterocyclic amine transformation activities of reuterin. Sci. Rep. 6:36246. doi:, PMID:
Not in our library10.1038/srep36246 (opens in a new tab)
51.
Evenepoel P. Poesen R. Meijers B. (2017 ). The gut–kidney axis. Pediatr. Nephrol. 32, 2005–2014
Not in our library10.1007/s00467-016-3527-x (opens in a new tab)
52.
Flemming A. (2019 ). Butyrate boosts microbicidal macrophages. Nat. Rev. Immunol. 19:135. doi:, PMID:
Not in our library10.1038/s41577-019-0132-9 (opens in a new tab)
53.
Flint H. J. Bayer E. A. Rincon M. T. Lamed R. White B. A. (2008 ). Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat. Rev. Microbiol. 6, 121–131. doi:, PMID:
Not in our library10.1038/nrmicro1817 (opens in a new tab)
54.
Franzosa E. A. Sirota-Madi A. Avila-Pacheco J. Fornelos N. Haiser H. J. Reinker S.. (2019 ). Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat. Microbiol. 4, 293–305. doi:, PMID:
Not in our library10.1038/s41564-018-0306-4 (opens in a new tab)
55.
Fujimoto T. Imaeda H. Takahashi K. Kasumi E. Bamba S. Fujiyama Y.. (2013 ). Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn’s disease. J. Gastroenterol. Hepatol. 28, 613–619
Not in our library10.1111/jgh.12073 (opens in a new tab)
56.
Butyrate-producing bacteria supplemented in vitro to Crohn’s disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity · 2017
No notice
57.
Geirnaert A. Steyaert A. Eeckhaut V. Debruyne B. Arends J. B. A. Van Immerseel F.. (2014 ). Butyricicoccus pullicaecorum, a butyrate producer with probiotic potential, is intrinsically tolerant to stomach and small intestine conditions. Anaerobe 30, 70–74. doi:, PMID:
Not in our library10.1016/j.anaerobe.2014.08.010 (opens in a new tab)
58.
Geng H.-W. Yin F.-Y. Zhang Z.-F. Gong X. Yang Y. (2021 ). Butyrate suppresses glucose metabolism of colorectal cancer cells via GPR109a-AKT signaling pathway and enhances chemotherapy. Front. Mol. Biosci. 8:634874
Not in our library10.3389/fmolb.2021.634874 (opens in a new tab)
59.
Gilijamse P. W. Hartstra A. V. Levin E. Wortelboer K. Serlie M. J. Ackermans M. T.. (2020 ). Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome. npj Biofilms Microbiomes 6:16. doi:, PMID:
Not in our library10.1038/s41522-020-0127-0 (opens in a new tab)
60.
Geography, Ethnicity or Subsistence-Specific Variations in Human Microbiome Composition and Diversity · 2017
No notice
61.
Gurry T. (2017 ). Synbiotic approaches to human health and well-being. Microb. Biotechnol. 10, 1070–1073. doi:, PMID:
Not in our library10.1111/1751-7915.12789 (opens in a new tab)
62.
Hajjar R. Richard C. S. Santos M. M. (2021 ). The role of butyrate in surgical and oncological outcomes in colorectal cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 320, G601–G608
Not in our library10.1152/ajpgi.00316.2020 (opens in a new tab)
63.
Hamer H. M. Jonkers D. Venema K. Vanhoutvin S. Troost F. J. Brummer R. J. (2008 ). Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27, 104–119. doi:, PMID:
Not in our library10.1111/j.1365-2036.2007.03562.x (opens in a new tab)
64.
Hanson B. T. Dimitri Kits K. Löffler J. Burrichter A. G. Fiedler A. Denger K.. (2021 ). Sulfoquinovose is a select nutrient of prominent bacteria and a source of hydrogen sulfide in the human gut. ISME J. 15, 2779–2791. doi:, PMID:
Not in our library10.1038/s41396-021-00968-0 (opens in a new tab)
65.
Healey G. Murphy R. Butts C. Brough L. Whelan K. Coad J. (2018 ). Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study. Br. J. Nutr. 119, 176–189. doi:, PMID:
Not in our library10.1017/s0007114517003440 (opens in a new tab)
66.
Hold G. L. Schwiertz A. Aminov R. I. Blaut M. Flint H. J. (2003 ). Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl. Environ. Microbiol. 69, 4320–4324. doi:, PMID:
Not in our library10.1128/aem.69.7.4320-4324.2003 (opens in a new tab)
67.
Huc T. Drapala A. Gawrys M. Konop M. Bielinska K. Zaorska E.. (2018 ). Chronic, low-dose TMAO treatment reduces diastolic dysfunction and heart fibrosis in hypertensive rats. Am. J. Phys. Heart Circ. Phys. 315, H1805–H1820
Not in our library10.1152/ajpheart.00536.2018 (opens in a new tab)
68.
Ihara S. Hirata Y. Koike K. (2017 ). TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota. J. Gastroenterol. 52, 777–787. doi:, PMID:
Not in our library10.1007/s00535-017-1350-1 (opens in a new tab)
69.
Iino C. Endo T. Mikami K. Hasegawa T. Kimura M. Sawada N.. (2019 ). Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI-and sex-matched population study. Hepatol. Int. 13, 748–756. doi:, PMID:
Not in our library10.1007/s12072-019-09987-8 (opens in a new tab)
70.
Isobe J. Maeda S. Obata Y. Iizuka K. Nakamura Y. Fujimura Y.. (2020 ). Commensal-bacteria-derived butyrate promotes the T-cell-independent IgA response in the colon. Int. Immunol. 32, 243–258. doi:, PMID:
Not in our library10.1093/intimm/dxz078 (opens in a new tab)
71.
Jaagura M. Part N. Adamberg K. Kazantseva J. Viiard E. (2022 ). Consumption of multi-fiber enriched yogurt is associated with increase of Bifidobacterium animalis and butyrate producing bacteria in human fecal microbiota. J. Funct. Foods 88:104899
Not in our library10.1016/j.jff.2021.104899 (opens in a new tab)
72.
Alteration of the gut microbiota in Chinese population with chronic kidney disease · 2017
No notice
73.
Jukic A. Bakiri L. Wagner E. F. Tilg H. Adolph T. E. (2021 ). Calprotectin: from biomarker to biological function. Gut 70, 1978–1988. doi:, PMID:
Not in our library10.1136/gutjnl-2021-324855 (opens in a new tab)
74.
Kamp K. Li N. Lachance D. M. Saad K. Tolentino E. Yoo L.. (2022 ). Interpersonal variability in gut microbial calprotectin metabolism. Gastro Hep Adv. 1, 853–856. doi:, PMID:
Not in our library10.1016/j.gastha.2022.05.007 (opens in a new tab)
75.
Kibbie J. J. Dillon S. M. Thompson T. A. Purba C. M. McCarter M. D. Wilson C. C. (2021 ). Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling. Immunobiology 226:152126. doi:, PMID:
Not in our library10.1016/j.imbio.2021.152126 (opens in a new tab)
76.
Kim H. Jeong Y. Kang S. You H. J. Ji G. E. (2020 ). Co-culture with Bifidobacterium catenulatum improves the growth, gut colonization, and butyrate production of Faecalibacterium prausnitzii: in vitro and in vivo studies. Microorganisms 8:788. doi:, PMID:
Not in our library10.3390/microorganisms8050788 (opens in a new tab)
77.
Cathelicidins: family of antimicrobial peptides. A review · 2012
No notice
78.
Krautkramer K. A. Fan J. Bäckhed F. (2021 ). Gut microbial metabolites as multi-kingdom intermediates. Nat. Rev. Microbiol. 19, 77–94. doi:, PMID:
Not in our library10.1038/s41579-020-0438-4 (opens in a new tab)
79.
Ku J.-L. Park S.-H. Yoon K.-A. Shin Y.-K. Kim K.-H. Choi J.-S.. (2007 ). Genetic alterations of the TGF-β signaling pathway in colorectal cancer cell lines: a novel mutation in Smad3 associated with the inactivation of TGF-β-induced transcriptional activation. Cancer Lett. 247, 283–292. doi:, PMID:
Not in our library10.1016/j.canlet.2006.05.008 (opens in a new tab)
80.
Leth M. L. Ejby M. Workman C. Ewald D. A. Pedersen S. S. Sternberg C.. (2018 ). Differential bacterial capture and transport preferences facilitate co-growth on dietary xylan in the human gut. Nat. Microbiol. 3, 570–580. doi:, PMID:
Not in our library10.1038/s41564-018-0132-8 (opens in a new tab)
81.
Li Q. Ding C. Meng T. Lu W. Liu W. Hao H.. (2017 ). Butyrate suppresses motility of colorectal cancer cells via deactivating Akt/ERK signaling in histone deacetylase dependent manner. J. Pharmacol. Sci. 135, 148–155. doi:, PMID:
Not in our library10.1016/j.jphs.2017.11.004 (opens in a new tab)
82.
Li X. Henson M. A. (2021 ). Dynamic metabolic modelling predicts efficient acetogen–gut bacterium cocultures for CO-to-butyrate conversion. J. Appl. Microbiol. 131, 2899–2917. doi:, PMID:
Not in our library10.1111/jam.15155 (opens in a new tab)
83.
Li M. Li G. Shang Q. Chen X. Liu W. Xe P.. (2016 ). In vitro fermentation of alginate and its derivatives by human gut microbiota. Anaerobe 39, 19–25. doi:, PMID:
Not in our library10.1016/j.anaerobe.2016.02.003 (opens in a new tab)
84.
Role of intestinal microbiota and metabolites on gut homeostasis and human diseases · 2017
No notice
85.
Litty D. Müller V. (2021 ). Butyrate production in the acetogen Eubacterium limosum is dependent on the carbon and energy source. Microb. Biotechnol. 14, 2686–2692. doi:, PMID:
Not in our library10.1111/1751-7915.13779 (opens in a new tab)
86.
Litvak Y. Byndloss M. X. Baumler A. J. (2018 ). Colonocyte metabolism shapes the gut microbiota. Science 362:eaat9076. doi:, PMID:
Not in our library10.1126/science.aat9076 (opens in a new tab)
87.
Litvak Y. Mon K. K. Nguyen H. Chanthavixay G. Liou M. Velazquez E. M.. (2019 ). Commensal Enterobacteriaceae protect against Salmonella colonization through oxygen competition. Cell Host Microbe 25:e5, 128–139.e5
Not in our library10.1016/j.chom.2018.12.003 (opens in a new tab)
88.
Liu J. Chang G. Huang J. Wang Y. Ma N. Roy A. C.. (2019 ). Sodium butyrate inhibits the inflammation of lipopolysaccharide-induced acute lung injury in mice by regulating the toll-like receptor 4/nuclear factor kappaB signaling pathway. J. Agric. Food Chem. 67, 1674–1682. doi:, PMID:
Not in our library10.1021/acs.jafc.8b06359 (opens in a new tab)
89.
Liu W. Yang Y. Zhang J. Gatlin D. M. Ringø E. Zhou Z. (2014 ). Effects of dietary microencapsulated sodium butyrate on growth, intestinal mucosal morphology, immune response and adhesive bacteria in juvenile common carp (Cyprinus carpio) pre-fed with or without oxidised oil. Br. J. Nutr. 112, 15–29
Not in our library10.1017/s0007114514000610 (opens in a new tab)
90.
Louis P. Flint H. J. (2009 ). Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 294, 1–8. doi:, PMID:
Not in our library10.1111/j.1574-6968.2009.01514.x (opens in a new tab)
91.
Louis P. Flint H. J. (2017 ). Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol. 19, 29–41
Not in our library10.1111/1462-2920.13589 (opens in a new tab)
92.
Luo J. Manning B. D. Cantley L. C. (2003 ). Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4, 257–262
Not in our library10.1016/s1535-6108(03)00248-4 (opens in a new tab)
93.
Maier E. Anderson R. C. Roy N. C. (2015 ). Understanding how commensal obligate anaerobic bacteria regulate immune functions in the large intestine. Nutrients 7, 45–73
Not in our library10.3390/nu7010045 (opens in a new tab)
94.
Malinowsky K. Nitsche U. Janssen K. P. Bader F. G. Späth C. Drecoll E.. (2014 ). Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer. Br. J. Cancer 110, 2081–2089. doi:, PMID:
Not in our library10.1038/bjc.2014.100 (opens in a new tab)
95.
Mallott E. K. Amato K. R. (2022 ). Butyrate production pathway abundances are similar in human and nonhuman primate gut microbiomes. Mol. Biol. Evol. 39
Not in our library10.1093/molbev/msab279 (opens in a new tab)
96.
Manson J. M. Rauch M. Gilmore M. S. (2008 ). “The commensal microbiology of the gastrointestinal tract” in GI Microbiota and Regulation of the Immune System. Advances in Experimental Medicine and Biology. eds. Huffnagle G. B. Noverr M. C., vol. 635 (New York, NY: Springer), 15–28.
Not in our library
97.
Identification of the novel role of butyrate as AhR ligand in human intestinal epithelial cells · 2019
No notice
98.
Martens E. C. Neumann M. Desai M. S. (2018 ). Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat. Rev. Microbiol. 16, 457–470. doi:, PMID:
Not in our library10.1038/s41579-018-0036-x (opens in a new tab)
99.
Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model · 2015
No notice
100.
Matamouros S. Hayden H. S. Hager K. R. Brittnacher M. J. Lachance K. Weiss E. J.. (2018 ). Adaptation of commensal proliferating Escherichia coli to the intestinal tract of young children with cystic fibrosis. Proc. Natl. Acad. Sci. 115, 1605–1610. doi:, PMID:
Not in our library10.1073/pnas.1714373115 (opens in a new tab)
101.
McLean P. G. Borman R. A. Lee K. (2007 ). 5-HT in the enteric nervous system: gut function and neuropharmacology. Trends Neurosci. 30, 9–13. doi:, PMID:
Not in our library10.1016/j.tins.2006.11.002 (opens in a new tab)
102.
Miller T. L. Wolin M. J. (1996 ). Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Appl. Environ. Microbiol. 62, 1589–1592. doi:, PMID:
Not in our library10.1128/aem.62.5.1589-1592.1996 (opens in a new tab)
103.
Identification of Metabolic Signatures Linked to Anti-Inflammatory Effects of <named-content content-type="genus-species">Faecalibacterium prausnitzii</named-content> · 2015
Not checked
104.
Miquel S. Martín R. Rossi O. Bermúdez-Humarán L. G. Chatel J. M. Sokol H.. (2013 ). Faecalibacterium prausnitzii and human intestinal health. Curr. Opin. Microbiol. 16, 255–261
Not in our library10.1016/j.mib.2013.06.003 (opens in a new tab)
105.
Mirande C. Kadlecikova E. Matulova M. Capek P. Bernalier-Donadille A. Forano E.. (2010 ). Dietary fibre degradation and fermentation by two xylanolytic bacteria Bacteroides xylanisolvens XB1AT and Roseburia intestinalis XB6B4 from the human intestine. J. Appl. Microbiol. 109, 451–460. doi:, PMID:
Not in our library10.1111/j.1365-2672.2010.04671.x (opens in a new tab)
106.
Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health · 2020
No notice
107.
Nagpal R. Tsuji H. Takahashi T. Nomoto K. Kawashima K. Nagata S.. (2017 ). Ontogenesis of the gut microbiota composition in healthy, full-term, vaginally born and breast-fed infants over the first 3 years of life: a quantitative bird’s-eye view. Front. Microbiol. 8:1388. doi:, PMID:
Not in our library10.3389/fmicb.2017.01388 (opens in a new tab)
108.
Obata Y. Castaño Á. Boeing S. Bon-Frauches A. C. Fung C. Fallesen T.. (2020 ). Neuronal programming by microbiota regulates intestinal physiology. Nature 578, 284–289. doi:, PMID:
Not in our library10.1038/s41586-020-1975-8 (opens in a new tab)
109.
Ohashi Y. Sumitani K. Tokunaga M. Ishihara N. Okubo T. TJBM F. (2015 ). Consumption of partially hydrolysed guar gum stimulates Bifidobacteria and butyrate-producing bacteria in the human large intestine. Benef Microbes 6, 451–455
Not in our library10.3920/bm2014.0118 (opens in a new tab)
110.
Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion · 2021
No notice
111.
Paillard D. McKain N. Chaudhary L. C. Walker N. D. Pizette F. Koppova I.. (2007 ). Relation between phylogenetic position, lipid metabolism and butyrate production by different Butyrivibrio-like bacteria from the rumen. Antonie Van Leeuwenhoek 91, 417–422. doi:, PMID:
Not in our library10.1007/s10482-006-9121-7 (opens in a new tab)
112.
Pan L. L. Niu W. Fang X. Liang W. Li H. Chen W.. (2019 ). Clostridium butyricum strains suppress experimental acute pancreatitis by maintaining intestinal homeostasis. Mol. Nutr. Food Res. 63:e1801419. doi:, PMID:
Not in our library10.1002/mnfr.201801419 (opens in a new tab)
113.
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases · 2019
Corrected
114.
Park J. Lee J. Yeom Z. Heo D. Lim Y.-H. (2017 ). Neuroprotective effect of Ruminococcus albus on oxidatively stressed SH-SY5Y cells and animals. Sci. Rep. 7:14520. doi:, PMID:
Not in our library10.1038/s41598-017-15163-5 (opens in a new tab)
115.
Pascal V. Pozuelo M. Borruel N. Casellas F. Campos D. Santiago A.. (2017 ). A microbial signature for Crohn’s disease. Gut 66, 813–822. doi:, PMID:
Not in our library10.1136/gutjnl-2016-313235 (opens in a new tab)
116.
Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights · 2019
No notice
117.
Pham V. T. Dold S. Rehman A. Bird J. K. Steinert R. E. (2021 ). Vitamins, the gut microbiome and gastrointestinal health in humans. Nutr. Res. 95, 35–53
Not in our library10.1016/j.nutres.2021.09.001 (opens in a new tab)
118.
Butyrate producing colonic Clostridiales metabolise human milk oligosaccharides and cross feed on mucin via conserved pathways · 2020
No notice
119.
Possemiers S. Rabot S. Espín J. C. Bruneau A. Philippe C. González-Sarrías A.. (2008 ). Eubacterium limosum activates isoxanthohumol from hops (Humulus lupulus L.) into the potent phytoestrogen 8-prenylnaringenin in vitro and in rat intestine. J. Nutr. 138, 1310–1316. doi:, PMID:
Not in our library10.1093/jn/138.7.1310 (opens in a new tab)
120.
Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome · 2015
No notice
121.
Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?Summary · 2020
Not checked
122.
Quévrain E. Maubert M. A. Michon C. Chain F. Marquant R. Tailhades J.. (2016 ). Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease. Gut 65, 415–425. doi:, PMID:
Not in our library10.1136/gutjnl-2014-307649 (opens in a new tab)
123.
Identification of mucin degraders of the human gut microbiota · 2021
No notice
124.
Reichardt N. Duncan S. H. Young P. Belenguer A. McWilliam Leitch C. Scott K. P.. (2014 ). Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 8, 1323–1335. doi:, PMID:
Not in our library10.1038/ismej.2014.14 (opens in a new tab)
125.
Rivera-Chávez F. Zhang L. F. Faber F. Lopez C. A. Byndloss M. X. Olsan E. E.. (2016 ). Depletion of butyrate-producing Clostridia from the gut microbiota drives an aerobic luminal expansion of salmonella. Cell Host Microbe 19, 443–454. doi:, PMID:
Not in our library10.1016/j.chom.2016.03.004 (opens in a new tab)
126.
Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut · 2016
No notice
127.
Rodríguez Hernáez J. Cerón Cucchi M. E. Cravero S. Martinez M. C. Gonzalez S. Puebla A.. (2018 ). The first complete genomic structure of Butyrivibrio fibrisolvens and its chromid. Microb Genom. 4:e000216
Not in our library10.1099/mgen.0.000216 (opens in a new tab)
128.
Saitoh Y. Suzuki H. Tani K. Nishikawa K. Irie K. Ogura Y.. (2015 ). Structural insight into tight junction disassembly by Clostridium perfringens enterotoxin. Science 347, 775–778. doi:, PMID:
Not in our library10.1126/science.1261833 (opens in a new tab)
129.
Salmerón A. M. Tristán A. I. Abreu A. C. Fernández I. (2022 ). Serum colorectal cancer biomarkers unraveled by NMR metabolomics: past, present, and future. Anal. Chem. 94, 417–430. doi:, PMID:
Not in our library10.1021/acs.analchem.1c04360 (opens in a new tab)
130.
Sartor R. (2011 ). Key questions to guide a better understanding of host–commensal microbiota interactions in intestinal inflammation. Mucosal Immunol. 4, 127–132. doi:, PMID:
Not in our library10.1038/mi.2010.87 (opens in a new tab)
131.
Sato T. Matsumoto K. Okumura T. Yokoi W. Naito E. Yoshida Y.. (2008 ). Isolation of lactate-utilizing butyrate-producing bacteria from human feces and in vivo administration of Anaerostipes caccae strain L2 and galacto-oligosaccharides in a rat model. FEMS Microbiol. Ecol. 66, 528–536. doi:, PMID:
Not in our library10.1111/j.1574-6941.2008.00528.x (opens in a new tab)
132.
Schirmer M. Garner A. Vlamakis H. Xavier R. J. (2019 ). Microbial genes and pathways in inflammatory bowel disease. Nat. Rev. Microbiol. 17, 497–511. doi:, PMID:
Not in our library10.1038/s41579-019-0213-6 (opens in a new tab)
133.
Schneider H. Blaut M. (2000 ). Anaerobic degradation of flavonoids by Eubacterium ramulus. Arch. Microbiol. 173, 71–75. doi:, PMID:
Not in our library10.1007/s002030050010 (opens in a new tab)
134.
The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages · 2019
No notice
135.
Trophic Interactions of Infant Bifidobacteria and Eubacterium hallii during L-Fucose and Fucosyllactose Degradation · 2017
No notice
136.
Revised Estimates for the Number of Human and Bacteria Cells in the Body · 2016
No notice
137.
Singh V. Muthuramalingam K. Kim Y. M. Park S. Kim S. H. Lee J.. (2021 ). Synbiotic supplementation with prebiotic Schizophyllum commune derived β-(1,3/1,6)-glucan and probiotic concoction benefits gut microbiota and its associated metabolic activities. Appl. Biol. Chem. 64:7
Not in our library10.1186/s13765-020-00572-4 (opens in a new tab)
138.
Singh V. Park Y.-J. Lee G. Unno T. Shin J.-H. (2022 ). Dietary regulations for microbiota dysbiosis among post-menopausal women 1. Crit. Rev. Food Sci. Nutr., 1–16
Not in our library10.1080/10408398.2022.2076651 (opens in a new tab)
139.
Singhal R. Donde H. Ghare S. Stocke K. Zhang J. Vadhanam M.. (2021 ). Decrease in acetyl-CoA pathway utilizing butyrate-producing bacteria is a key pathogenic feature of alcohol-induced functional gut microbial dysbiosis and development of liver disease in mice. Gut Microbes 13:1946367. doi:, PMID:
Not in our library10.1080/19490976.2021.1946367 (opens in a new tab)
140.
Stoeva M. K. Garcia-So J. Justice N. Myers J. Tyagi S. Nemchek M.. (2021 ). Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease. Gut Microbes 13, 1–28. doi:, PMID:
Not in our library10.1080/19490976.2021.1907272 (opens in a new tab)
141.
Sun C. Zhao C. Guven E. C. Paoli P. Simal-Gandara J. Ramkumar K. M.. (2020 ). Dietary polyphenols as antidiabetic agents: advances and opportunities. Food Front. 1, 18–44
Not in our library10.1002/fft2.15 (opens in a new tab)
142.
Suo Y. Ren M. Yang X. Liao Z. Fu H. Wang J. (2018 ). Metabolic engineering of clostridium tyrobutyricum for enhanced butyric acid production with high butyrate/acetate ratio. Appl. Microbiol. Biotechnol. 102, 4511–4522. doi:, PMID:
Not in our library10.1007/s00253-018-8954-0 (opens in a new tab)
143.
Tandon D. Haque M. M. Gote M. Jain M. Bhaduri A. Dubey A. K.. (2019 ). A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora. Sci. Rep. 9, 1–15
Not in our library10.1038/s41598-019-41837-3 (opens in a new tab)
144.
tom Dieck H. Schön C. Wagner T. Pankoke H. C. Fluegel M. Speckmann B. (2022 ). A synbiotic formulation comprising Bacillus subtilis DSM 32315 and L-Alanyl-L-glutamine improves intestinal butyrate levels and lipid metabolism in healthy humans. Nutrients 14:143
Not in our library10.3390/nu14010143 (opens in a new tab)
145.
Tong L. Feng Q. Lu Q. Zhang J. Xiong Z. (2022 ). Combined 1H NMR fecal metabolomics and 16S rRNA gene sequencing to reveal the protective effects of Gushudan on kidney-yang-deficiency-syndrome rats via gut-kidney axis. J. Pharm. Biomed. Anal. 217:114843. doi:, PMID:
Not in our library10.1016/j.jpba.2022.114843 (opens in a new tab)
146.
Key bacterial taxa and metabolic pathways affecting gut short-chain fatty acid profiles in early life · 2021
No notice
147.
Converting Carbon Dioxide to Butyrate with an Engineered Strain of <named-content content-type="genus-species">Clostridium ljungdahlii</named-content> · 2014
Not checked
148.
Valles-Colomer M. Falony G. Darzi Y. Tigchelaar E. F. Wang J. Tito R. Y.. (2019 ). The neuroactive potential of the human gut microbiota in quality of life and depression. Nat. Microbiol. 4, 623–632. doi:, PMID:
Not in our library10.1038/s41564-018-0337-x (opens in a new tab)
149.
Van den Abbeele P. Gérard P. Rabot S. Bruneau A. El Aidy S. Derrien M.. (2011 ). Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats. Environ. Microbiol. 13, 2667–2680. doi:, PMID:
Not in our library10.1111/j.1462-2920.2011.02533.x (opens in a new tab)
150.
Cathelicidins: Immunomodulatory Antimicrobials · 2018
No notice
151.
The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis · 2010
No notice
152.
Vieira E. L. Leonel A. J. Sad A. P. Beltrao N. R. Costa T. F. Ferreira T. M.. (2012 ). Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. J. Nutr. Biochem. 23, 430–436. doi:, PMID:
Not in our library10.1016/j.jnutbio.2011.01.007 (opens in a new tab)
153.
Vincent A. D. Wang X.-Y. Parsons S. P. Khan W. I. Huizinga J. D. (2018 ). Abnormal absorptive colonic motor activity in germ-free mice is rectified by butyrate, an effect possibly mediated by mucosal serotonin. Am. J. Physiol. Gastrointest. Liver Physiol. 315, G896–G907
Not in our library10.1152/ajpgi.00237.2017 (opens in a new tab)
154.
Revealing the Bacterial Butyrate Synthesis Pathways by Analyzing (Meta)genomic Data · 2014
Not checked
155.
Colonic Butyrate-Producing Communities in Humans: an Overview Using Omics Data · 2017
No notice
156.
A gene-targeted approach to investigate the intestinal butyrate-producing bacterialcommunity · 2013
No notice
157.
Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor · 2021
Not checked
158.
Wang R. X. Lee J. S. Campbell E. L. Colgan S. P. (2020 ). Microbiota-derived butyrate dynamically regulates intestinal homeostasis through regulation of actin-associated protein synaptopodin. Proc. Natl. Acad. Sci. 117, 11648–11657. doi:, PMID:
Not in our library10.1073/pnas.1917597117 (opens in a new tab)
159.
Werlang M. E. Palmer W. C. Lacy B. E. (2019 ). Irritable bowel syndrome and dietary interventions. Gastroenterol. Hepatol. 15, 16–26.
Not in our library
160.
Bacteroides thetaiotaomicron and Faecalibacterium prausnitziiinfluence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent · 2013
No notice
161.
Wu J. Zhou B. Pang X. Song X. Gu Y. Xie R.. (2022 ). Clostridium butyricum, a butyrate-producing potential probiotic, alleviates experimental colitis through epidermal growth factor receptor activation. Food Funct. 13, 7046–7061. doi:, PMID:
Not in our library10.1039/d2fo00478j (opens in a new tab)
162.
Xi Y. Jing Z. Wei W. Chun Z. Quan Q. Qing Z.. (2021 ). Inhibitory effect of sodium butyrate on colorectal cancer cells and construction of the related molecular network. BMC Cancer 21:127. doi:, PMID:
Not in our library10.1186/s12885-021-07845-1 (opens in a new tab)
163.
Comprehensive review of targeted therapy for colorectal cancer · 2020
No notice
164.
Yadav H. Lee J.-H. Lloyd J. Walter P. Rane S. G. (2013 ). Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion*. J. Biol. Chem. 288, 25088–25097. doi:, PMID:
Not in our library10.1074/jbc.m113.452516 (opens in a new tab)
165.
Possible role of the gut microbiota–brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model · 2017
No notice
166.
Yang T. Richards E. M. Pepine C. J. Raizada M. K. (2018 ). The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease. Nat. Rev. Nephrol. 14, 442–456. doi:, PMID:
Not in our library10.1038/s41581-018-0018-2 (opens in a new tab)
167.
Butyrate Shapes Immune Cell Fate and Function in Allergic Asthma · 2021
No notice
168.
Metabolism of Dietary and Microbial Vitamin B Family in the Regulation of Host Immunity · 2019
No notice
169.
Ze X. Duncan S. H. Louis P. Flint H. J. (2012 ). Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J. 6, 1535–1543. doi:, PMID:
Not in our library10.1038/ismej.2012.4 (opens in a new tab)
170.
Zhao Z. Liu W. Pi X. (2021 ). In vitro effects of stachyose on the human gut microbiota. Starch 73:2100029
Not in our library10.1002/star.202100029 (opens in a new tab)
171.
Zheng L. Kelly C. J. Battista K. D. Schaefer R. Lanis J. M. Alexeev E. E.. (2017 ). Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor–dependent repression of claudin-2. J. Immunol. 199, 2976–2984. doi:, PMID:
Not in our library10.4049/jimmunol.1700105 (opens in a new tab)
172.
Claudin Family Participates in the Pathogenesis of Inflammatory Bowel Diseases and Colitis-Associated Colorectal Cancer · 2019
No notice
173.
Zou S. Fang L. Lee M.-H. (2018 ). Dysbiosis of gut microbiota in promoting the development of colorectal cancer. Gastroenterol. Rep. 6, 1–12
Not in our library10.1093/gastro/gox031 (opens in a new tab)

Cited by papers we hold 2

Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease · 2023
No notice
Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota · 2023
No notice

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.